Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
405 | 3 | MAST CELLS//EOSINOPHILS//EOSINOPHILIC ESOPHAGITIS | 31210 |
683 | 2 | EOSINOPHILS//OMALIZUMAB//ALLERGY | 13558 |
11630 | 1 | OMALIZUMAB//ANTI IGE//ANTI IMMUNOGLOBULIN E | 993 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | OMALIZUMAB | authKW | 5446922 | 31% | 56% | 305 |
2 | ANTI IGE | authKW | 1507637 | 10% | 47% | 102 |
3 | ANTI IMMUNOGLOBULIN E | authKW | 583170 | 2% | 88% | 21 |
4 | IGE | authKW | 302674 | 20% | 5% | 200 |
5 | FC EPSILON RI | authKW | 277841 | 6% | 15% | 57 |
6 | ANTI IGE ANTIBODY | authKW | 202108 | 1% | 58% | 11 |
7 | HIGH AFFINITY IGE RECEPTOR | authKW | 193428 | 2% | 38% | 16 |
8 | ALLERGIC ASTHMA | authKW | 176943 | 6% | 9% | 61 |
9 | RHUMAB E25 | authKW | 158687 | 1% | 100% | 5 |
10 | XOLAIR | authKW | 151211 | 1% | 53% | 9 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Allergy | 62730 | 37% | 1% | 367 |
2 | Immunology | 9232 | 46% | 0% | 456 |
3 | Respiratory System | 2141 | 13% | 0% | 125 |
4 | Biochemistry & Molecular Biology | 176 | 15% | 0% | 152 |
5 | Dermatology | 158 | 4% | 0% | 35 |
6 | Medicine, Research & Experimental | 153 | 6% | 0% | 58 |
7 | Critical Care Medicine | 101 | 2% | 0% | 23 |
8 | Pharmacology & Pharmacy | 85 | 8% | 0% | 80 |
9 | Medicine, General & Internal | 75 | 6% | 0% | 57 |
10 | Pediatrics | 17 | 3% | 0% | 25 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL BIOLBUNKYO KU | 71408 | 0% | 75% | 3 |
2 | ALLERGY BUNKYO KU | 63475 | 0% | 100% | 2 |
3 | ARBEITSGRP PNEUMOL ALLERGOL MUKOVISZIDOSE | 63475 | 0% | 100% | 2 |
4 | RCMB | 46158 | 0% | 36% | 4 |
5 | PEDIAT P DIS ALLERGY | 42315 | 0% | 67% | 2 |
6 | ALLERGY IMMUNOLLEBONHEUR HOSP | 31737 | 0% | 100% | 1 |
7 | ALLERGY MOL BIOL | 31737 | 0% | 100% | 1 |
8 | AZIENDA OSPED UNIV POLICLIN VITTORIO EMANUL | 31737 | 0% | 100% | 1 |
9 | BIOMED DIAG SCI | 31737 | 0% | 100% | 1 |
10 | BREAST CANC NOW UNIT ONCOL | 31737 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 16361 | 5% | 1% | 47 |
2 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 12347 | 7% | 1% | 65 |
3 | ALLERGY AND ASTHMA PROCEEDINGS | 10293 | 2% | 1% | 23 |
4 | JOURNAL OF ASTHMA | 8628 | 3% | 1% | 29 |
5 | ALLERGY | 7984 | 4% | 1% | 40 |
6 | ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 6120 | 3% | 1% | 27 |
7 | CURRENT ALLERGY AND ASTHMA REPORTS | 6006 | 1% | 1% | 14 |
8 | MOLECULAR IMMUNOLOGY | 4493 | 3% | 0% | 32 |
9 | CLINICAL AND EXPERIMENTAL ALLERGY | 3230 | 2% | 0% | 23 |
10 | ALLERGOLOGIE | 3174 | 1% | 1% | 14 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OMALIZUMAB | 5446922 | 31% | 56% | 305 | Search OMALIZUMAB | Search OMALIZUMAB |
2 | ANTI IGE | 1507637 | 10% | 47% | 102 | Search ANTI+IGE | Search ANTI+IGE |
3 | ANTI IMMUNOGLOBULIN E | 583170 | 2% | 88% | 21 | Search ANTI+IMMUNOGLOBULIN+E | Search ANTI+IMMUNOGLOBULIN+E |
4 | IGE | 302674 | 20% | 5% | 200 | Search IGE | Search IGE |
5 | FC EPSILON RI | 277841 | 6% | 15% | 57 | Search FC+EPSILON+RI | Search FC+EPSILON+RI |
6 | ANTI IGE ANTIBODY | 202108 | 1% | 58% | 11 | Search ANTI+IGE+ANTIBODY | Search ANTI+IGE+ANTIBODY |
7 | HIGH AFFINITY IGE RECEPTOR | 193428 | 2% | 38% | 16 | Search HIGH+AFFINITY+IGE+RECEPTOR | Search HIGH+AFFINITY+IGE+RECEPTOR |
8 | ALLERGIC ASTHMA | 176943 | 6% | 9% | 61 | Search ALLERGIC+ASTHMA | Search ALLERGIC+ASTHMA |
9 | RHUMAB E25 | 158687 | 1% | 100% | 5 | Search RHUMAB+E25 | Search RHUMAB+E25 |
10 | XOLAIR | 151211 | 1% | 53% | 9 | Search XOLAIR | Search XOLAIR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |